Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1977 Feb;59(2):367–371. doi: 10.1111/j.1476-5381.1977.tb07501.x

Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.

A R Green
PMCID: PMC1667726  PMID: 264797

Abstract

1 The hyperactivity syndrome produced in rats by administration of tranylcypromine (20 mg/kg i.p.) followed 30 min later by L-tryptophan (50 mg/kg i.p.) is generally considered to be due to increased 5-hydroxytryptamine (5-HT) functional activity. It is inhibited by chlorpromazine (30 mg/kg i.p.) injected 60 min before the tranylcypromine. However, chlorpromazine injection for 4 days either at a dose of 30 mg/kg once daily or 5 mg/kg twice daily results in an enhanced hyperactivity response to tranylcypromine and L-tryptophan administration 24 h after the final dose of chlorpromazine. 2 One injection of chlorpromazine (30 mg/kg) did not produce enhancement 24 h later and the inhibition of the tranylcypromine/L-tryptophan hyperactivity observed after acute chlorpromazine injection was seen if the rats were given tranylcypromine and L-tryptophan 1 h after the fourth chlorpromazine (30 mg/kg) dose. 3 Chlorpromazine (30 mg/kg) once daily or 5 mg/kg twice daily for 4 days resulted in rats displaying enhanced behavioral responses to the suggested 5-HT agonist 5-methoxy N,N-dimethyltryptamine (2 mg/kg) on day 5. 4 Chlorpromazine (30 mg/kg) once daily for 4 days produces a slight increase in brain 5-hydroxytryptamine (5-HT) concentration on day 5, but no difference in the rate of brain 5-HT synthesis or the rate of 5-HT accumulation after tranylcypromine and L-tryptophan administration. 5. There is some evidence that chlorpromazine blocks 5-HT receptors. It has also been observed that several other neuroleptic drugs do not produce enhanced 5-HT responses after repeated administration. It is suggested therefore that the enhanced behavioural response to 5-HT receptor stimulation following repeated chlorpromazine administration may be because this drug blocks 5-HT receptors.

Full text

PDF
367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bender D. A. The effects of chlorpromazine on serum tryptophan, brain tryptophan uptake and brain serotonin synthesis in the rat. Biochem Pharmacol. 1976 Aug 1;25(15):1743–1746. doi: 10.1016/0006-2952(76)90408-1. [DOI] [PubMed] [Google Scholar]
  2. Curzon G., Green A. R. Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol. 1970 Jul;39(3):653–655. doi: 10.1111/j.1476-5381.1970.tb10373.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Denckla W. D., Dewey H. K. The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med. 1967 Jan;69(1):160–169. [PubMed] [Google Scholar]
  4. Dominic J. A., Moore K. E. Supersensitivity to the central stimulant actions of adrenergic drugs following discontinuation of a chronic diet of alpha-methyltyrosine. Psychopharmacologia. 1969;15(2):96–101. doi: 10.1007/BF00407041. [DOI] [PubMed] [Google Scholar]
  5. Gianutsos G., Drawbaugh R. B., Hynes M. D., Lal H. Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol. Life Sci. 1974 Mar 1;14(5):887–898. doi: 10.1016/0024-3205(74)90078-2. [DOI] [PubMed] [Google Scholar]
  6. Grahame-Smith D. G. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem. 1971 Jun;18(6):1053–1066. doi: 10.1111/j.1471-4159.1971.tb12034.x. [DOI] [PubMed] [Google Scholar]
  7. Green A. R., Grahame-Smith D. G. Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature. 1976 Apr 8;260(5551):487–491. doi: 10.1038/260487a0. [DOI] [PubMed] [Google Scholar]
  8. Green A. R., Grahame-Smith D. G. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. Neuropharmacology. 1974 Nov;13(10-11):949–959. doi: 10.1016/0028-3908(74)90086-0. [DOI] [PubMed] [Google Scholar]
  9. Heal D. J., Green A. R., Boullin D. J., Grahame-Smith D. G. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa. Psychopharmacology (Berl) 1976 Sep 29;49(3):287–300. doi: 10.1007/BF00426832. [DOI] [PubMed] [Google Scholar]
  10. Klawans H. L., D'Amico D. J., Patel B. C. Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment. Psychopharmacologia. 1975 Nov 21;44(3):297–300. doi: 10.1007/BF00428910. [DOI] [PubMed] [Google Scholar]
  11. Moore K. E., Thornburg J. E. Drug-induced dopaminergic supersensitivity. Adv Neurol. 1975;9:93–104. [PubMed] [Google Scholar]
  12. Neff N. H., Tozer T. N. In vivo measurement of brain serotonin turnover. Adv Pharmacol. 1968;6(Pt A):97–109. doi: 10.1016/s1054-3589(08)61160-6. [DOI] [PubMed] [Google Scholar]
  13. Tarsy D., Baldessarini R. J. Pharmacologically induced behavioural supersensitivity to apomorphine. Nat New Biol. 1973 Oct 31;245(148):262–263. doi: 10.1038/newbio245262a0. [DOI] [PubMed] [Google Scholar]
  14. Trulson M. E., Eubanks E. E., Jacobs B. L. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine. J Pharmacol Exp Ther. 1976 Jul;198(1):23–32. [PubMed] [Google Scholar]
  15. von Hungen K., Roberts S., Hill D. F. Serotonin-sensitive adenylate cyclase activity of immature rat brain. Brain Res. 1975 Feb 7;84(2):257–267. doi: 10.1016/0006-8993(75)90980-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES